Lobbying activity

Q1

THE MCMANUS GROUP for FULCRUM THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income

Health Issues

View → Q1

DANA-FARBER CANCER INSTITUTE for DANA-FARBER CANCER INSTITUTE

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate

Budget/Appropriations, Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs

View → Q1

RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Pharmacy, Trade (domestic/foreign)

View → Q1

SMITHBUCKLIN CORPORATION for ASTCT

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $70,000.00 income

Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid

View → Q1

NATIONWIDE CHILDREN'S HOSPITAL, INC. for NATIONWIDE CHILDREN'S HOSPITAL INC

1st Quarter (Jan 1 - Mar 31) 2026 · Ohio · House · Senate

Health Issues, Medicare/Medicaid

View → Q1

BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Pharmacy

View → Q1

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security

View → Q1

TOURETTE ASSOCIATION OF AMERICA for TOURETTE ASSOCIATION OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Education, Health Issues, Medicare/Medicaid

View → Q1

ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Budget/Appropriations

View → Q1

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate

Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q1

TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Copyright/Patent/Trademark, Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs

View → Q1

MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues, Pharmacy

View → Q1

NOVARTIS for NOVARTIS

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Labor Issues/Antitrust/Workplace, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues

View → Q1

NATIONAL HEALTH COUNCIL for NATIONAL HEALTH COUNCIL

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues, Budget/Appropriations

View → Q1

AKIN GUMP STRAUSS HAUER & FELD for BIOTECHNOLOGY INNOVATION ORGANIZATION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Small Business

View → Q1

EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Health Issues

View → Q1

DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Pharmacy, Medical/Disease Research/Clinical Labs, Health Issues

View → Q1

THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $40,000.00 income

Pharmacy

View → Q1

BRACEWELL LLP for AQUESTIVE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · Indiana · House · Senate · $60,000.00 income

Consumer Issues/Safety/Products, Health Issues

View → Q1

ARNOLD & PORTER KAYE SCHOLER LLP for NEURELIS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $10,000.00 income

Health Issues

View → Q1

MEHLMAN CONSULTING, INC. for ULTRAGENYX PHARMACEUTICAL, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income

Health Issues, Budget/Appropriations

View → Q1

MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $90,000.00 income

Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Taxation/Internal Revenue Code

View → Q1

LMH STRATEGIC SOLUTIONS for PTC THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income

Health Issues

View →